• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Model Number 10605
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Cardiogenic Shock (2262)
Event Date 08/28/2017
Event Type  Death  
Manufacturer Narrative
Device is a combination product.
 
Event Description
(b)(6) study.It was reported that cardiogenic shock and death occurred.In (b)(6) 2016, due to a clinical status assessment indicating the qualifying condition of unstable angina, the patient was referred for cardiac catheterization.The target lesion was 95% stenosed, 20 mm long with a reference vessel diameter of 2.5 mm located in the distal right coronary artery (rca).The target lesion was treated with pre dilatation and placement of a 2.75 x 28 mm study stent with 0% residual stenosis.The patient was discharged on dual antiplatelet therapy.In (b)(6) 2017, the patient was diagnosed with non-st segment elevation myocardial infarction considered not related to the device.As there were no acute wall motion abnormalities in the distribution of the previously placed bypass grafts, the physician deemed that no coronary angiography was required.Two days later, the ejection fraction was improved from 30% to 50% and wall motion abnormality was consistent with obstruction of the posterior circumflex artery per analysis.The patient had a change in medication dose of isosorbide mononitrate along with reduction of dose in amlodipine during the hospital course.The patient was discharged with dual anti-platelet medications.Twenty days later the patient was hospitalized due to cardiogenic shock.On the same day, the patient expired.The cause of death was cardiogenic shock.It was unknown whether an autopsy was performed or not.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
BIODEGRADABLE POLYMER DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
sonali arangil
two scimed place
maple grove, MN 55311
6515827403
MDR Report Key8417572
MDR Text Key138699859
Report Number2134265-2019-02362
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729840282
UDI-Public08714729840282
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 03/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/23/2016
Device Model Number10605
Device Catalogue Number10605
Device Lot Number0018468288
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/20/2019
Initial Date FDA Received03/13/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age64 YR
-
-